相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Permeabilizing Cell Membranes with Electric Fields
Alondra A. Aguilar et al.
CANCERS (2021)
Progress and prospect in tumor treating fields treatment of glioblastoma
Shiyu Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Tumour treating fields therapy for glioblastoma: current advances and future directions
Ola Rominiyi et al.
BRITISH JOURNAL OF CANCER (2021)
Physiologic MR imaging of the tumor microenvironment revealed switching of metabolic phenotype upon recurrence of glioblastoma in humans
Andreas Stadlbauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma
Jia Wang et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma
Yan Zhou et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy
Tali Voloshin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
Wahafu Alafate et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Hyperpolarized 13C MRI: A novel approach for probing cerebral metabolism in health and neurological disease
James T. Grist et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
B3GNT5 is a novel marker correlated with stem-like phenotype and poor clinical outcome in human gliomas
Hang Yeon Jeong et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis
Zujian Xiong et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
Ashley P. Ghiaseddin et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
Mario E. Lacouture et al.
FRONTIERS IN ONCOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*
Nathalie Percie du Sert et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
Francesca A. Carrieri et al.
FRONTIERS IN ONCOLOGY (2020)
Review of clinical nerve repair strategies for neurorestoration of central nervous system tumor damage
Xinyu Wang et al.
JOURNAL OF NEURORESTORATOLOGY (2020)
MGMT Status as a Clinical Biomarker in Glioblastoma
Madison Butler et al.
TRENDS IN CANCER (2020)
What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Abbie S. Ornelas et al.
NEUROLOGIST (2019)
Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies
Daniel Dubinski et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies
Yuefeng Wang et al.
ONCOLOGIST (2019)
EXTH-02. THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
Ellina Schulz et al.
NEURO-ONCOLOGY (2019)
Impact of preoperative Karnofsky Performance Scale (KPS) and American Society of Anesthesiologists (ASA) scores on perioperative complications in patients with recurrent glioma undergoing repeated operation
Zhong Deng et al.
JOURNAL OF NEURORESTORATOLOGY (2019)
Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia
Andreas Stadlbauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma A Secondary Analysis of a Randomized Clinical Trial
Martin J. B. Taphoorn et al.
JAMA ONCOLOGY (2018)
TUMOR TREATING FIELDS TECHNOLOGY: ALTERNATING ELECTRIC FIELD THERAPY FOR THE TREATMENT OF SOLID TUMORS
Laura Benson
SEMINARS IN ONCOLOGY NURSING (2018)
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot study
Ignace Vergote et al.
GYNECOLOGIC ONCOLOGY (2018)
P04.16 Tumor treating fields affect invasion properties and cell morphology of various cancer cells
R Schneiderman et al.
NEURO-ONCOLOGY (2018)
Tumor treating fields increases membrane permeability in glioblastoma cells
Edwin Chang et al.
CELL DEATH DISCOVERY (2018)
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Elijah J. Mun et al.
CLINICAL CANCER RESEARCH (2018)
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma A Randomized Clinical Trial
Roger Stupp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines
Narasimha Kumar Karanam et al.
CELL DEATH & DISEASE (2017)
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
Kenneth D. Swanson et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Tumor treating fields: a novel treatment modality and its use in brain tumors
Andreas F. Hottinger et al.
NEURO-ONCOLOGY (2016)
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Eric T. Wong et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)
The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
Azeem A. Rehman et al.
NEUROSURGICAL FOCUS (2015)
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system
Scott G. Turner et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Immortality of cell lines: challenges and advantages of establishment
Muhammad Irfan Maqsood et al.
CELL BIOLOGY INTERNATIONAL (2013)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs
Eilon D. Kirson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
Eilon D. Kirson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
分享论文
